Global Vaccines Market 2020-2026
1
Transilience Market Research | Sales@transiliencemarketresearch.com
Global Vaccines Market 2020 By Technology [Conjugate vaccines, Inactivated and subunit vaccines, Live attenuated vaccines, Recombinant vaccines, Toxoid vaccines and others],By Type [Monovalent vaccines, Multivalent vaccines and others], By Patient Type[Pediatric patients, Adult patients and others], By Disease[Cancer, Dengue, DTP, Hepatitis, Human Papilloma Virus, Influenza, Meningococcal Disease, Pneumococcal disease, Polio, Rotavirus and others]: Global Forecast to 2026 and COVID-19 Impact Outlook Global Vaccines Market is valued at USD 45.9 Billion in 2019 and expected to reach USD 91.9 Billion by 2026 with the CAGR of 10.44 % over the forecast period.
Scope of the report A vaccine is a biological preparation that provides immunity against disease. Vaccines are best health interventions available today to prevent infectious diseases such as influenza, measles, mumps and other. Widespread use of vaccines has resulted in considerable progress against some of the most devastating human diseases. Many new approaches are being adopted in development of vaccine such as DNA vaccines, Peptide vaccines which could help in faster antigen detection and induce effective immune response. Further advancement in vaccine preservation techniques, drug delivery systems will facilitate growth in forecast period. KNOW MORE This report analyses the global market for Vaccines. The report will enable the user to understand and gain insights into the current and forecast market situation. The market is comprehensively analyzed by geography to give complete information on the global scenario. The qualitative and quantitative data provided in this study can help user understand which market segments, regions are expected to grow at higher rates, factors affecting the market and key opportunity areas. The report also includes competitive landscape of key players in the industry along with emerging trends in the market.
Key Players 1. Abbott Laboratories Inc. 2. AstraZeneca Plc 3. CSL Ltd. 4. Emergent BioSolutions Inc. 5. GlaxoSmithKline Plc. 6. Janssen Pharmaceuticals Inc. 7. Johnson and Johnson
Transilience Market Research | Sales@transiliencemarketresearch.com
2
8. Merck &Co. Inc. 9. Novartis AG 10. Pfizer Inc. 11. Sanofi Pasteur Inc. 12. Takeda Pharmaceuticals Company Ltd. 13. Valeant Pharmaceuticals International Inc. 14. others Above mentioned companies were scrutinized to assess competitive landscape of global Vaccines market. Report provides company profiles of each player. Each profile include company product portfolio,business overview, company governance, company financials, business strategies, manufacturing locations and production facilities, company sale, recent developments and strategic collaborations & partnerships, new product launch, company segments, application diversification and company strength and weakness analysis.
Review period: (2016-2026) Historic Period: 2016 to 2019 Forecast Period: 2020 to 2026 Base Year: 2019 Unit: USD Billion This Vaccines market report provides insights on new trade regulations, import export analysis, industry value chain analysis, market size, consumption, production analysis, regional and segment market share, product launches, product pipeline analysis, impact of Covid-19 on supply chain, key regions, untapped markets, patent analysis, product approvals, continuous innovations and developments in the market.
REQUEST SAMPLE
3
Transilience Market Research | Sales@transiliencemarketresearch.com
Regions
North America: U.S., Canada and Rest of North America
Europe: UK, France, Germany, Italy, Spain and Rest of Europe
Asia Pacific: China, Japan, India, Australia, Southeast Asia and Rest of Asia Pacific
Latin America: Brazil, Mexico, Argentina and Rest of Latin America
Middle East and Africa: Gulf Countries, Israel, Africa and Rest of Middle East and Africa
[visualizer id="855"]
Regional Insights North America dominates the global vaccine market. The growth in the region was primarily driven by presence of advanced healthcare infrastructure, prevalence of infectious diseases, key players with robust research and development capabilities and growing private and government capital investments for the development of vaccines. Asia Pacific is the fastest growing market which recorded highest CAGR in 2019. Proactive measures of government to tackle the growing infectious diseases, investments on development of healthcare infrastructure, rising prevalence of infectious diseases are some driving the growth of vaccine market in this region. Further developing biopharmaceutical sector has brought significant growth opportunities. The region has large number of vaccine manufacturers offering low cost production solutions for licenced vaccine manufacturers and has seen unprecedented growth in vaccine development. The manufacturers are providing market with innovative products such as cholera vaccines, hepatitis A vaccines, typhoid glycoconjugate vaccine, rotavirus vaccines etc. Rising investments in COVID 19 vaccine production is expected to offer lucrative growth opportunities in future. For instance Chinese biopharmaceutical products company Sinovac Biotech has received $15m funding to advance the development of its CoronaVac Covid-19 vaccine.
Global Vaccines Market Dynamics Progress has already been made with several therapeutic vaccines for cancer, diabetes, hypertension and Alzheimer's disease. According to the WHO (World Health Organization) in 2019 were more than 240 vaccines in development for 25 infectious diseases.
HIV/AIDS, malaria,
pneumococcal infections, tuberculosis, and Ebola vaccine are the major diseases leading the way. Increasing company initiatives to enhance vaccine R&D, growing prevalence of infectious diseases and exploding population growth are the major drivers for the growth of global vaccine market. In addition to this spread of novel coronavirus around the world has resulted into fast track vaccine
Transilience Market Research | Sales@transiliencemarketresearch.com
4
development to control the disease. There are 321 candidates in coronavirus vaccine development as of October 2020. Out of which 44 vaccine candidates were conducting clinical trials 34 in Phase I– II trials and 10 in Phase II–III trial. Stringent regulatory policies, complexity of vaccine development, longer clinical trials are factors hampering the growth of global market. Growing investments and on-going research on vaccine developments are expected to foster the market growth in forecast period.
Market Segmentation
Technology o Conjugate vaccines o Inactivated and subunit vaccines o Live attenuated vaccines o Recombinant vaccines o Toxoid vaccines Type o Monovalent vaccines o Multivalent vaccines Patient Type o Pediatric patients o Adult patients Disease o Cancer o Dengue o DTP o Hepatitis o Human Papilloma Virus o Influenza o Meningococcal Disease o Pneumococcal disease o Polio o Rotavirus
Report Coverage
An overview of the global Vaccines market
In depth analysis of market dynamics and major factors such as drivers, restraints, opportunities and trends influencing the global market
Global Vaccines market revenue data historic and forecast analysis (2016 to 2026)
Characterization and quantification of the market segments for Vaccines market
Market share analysis of key market participants and their competitive landscape
Transilience Market Research | Sales@transiliencemarketresearch.com
5
Important Questions Answered by Global Vaccines Market Report
What is the impact of COVID 19 epidemic on the global Vaccines market?
Which is mostly affected region, country?
Which is the current largest and fastest-growing region?
What is the market size and growth rate of the global Vaccines market?
What are current factors affecting the growth of market?
What are Key trends and opportunity areas?
Within Vaccines market, which segments are fastest growing & emerging strongly? What are the drivers and restraints for each segment? What are vendor competencies by segment?
What are the major strategies adopted by leading market companies?
What are company challenges and essential success factors by market segment?
How company offerings and supply chain capabilities are shifting to meet emerging market needs?
Global Vaccines Market COVID-19 impact Analysis This report highlights the impact of the Covid-19 pandemic on Global Vaccines Market.
By
combining data from a range of industry sources, as well as predictive modelling and market trend analysis, we provide an evidence-based set of projections that will allow organisations to plan their strategies more effectively. The report gives in depth analysis of short term and long term impacts of epidemic on the industry. The COVID 19 impact assessment of Global Vaccines Market is divided into following sections: Section1: Pre Lockdown This part of the report looks at how market changed throughout early 2020, as the spread of COVID19 intensified on different geographies. Section2: During Lockdown This part of the report collects data from across the sector to know how people have responded to lockdown. It analyses the impact of the epidemic on the workforce in the industry and disruption in various regions and countries Section3: Post Lockdown
Transilience Market Research | Sales@transiliencemarketresearch.com
6
This part of the report project what sector recovery could look like and summarises ways in which the business landscape could shift. Get detailed COVID 19 Impact Analysis on Global Vaccines Market Here
7
Transilience Market Research | Sales@transiliencemarketresearch.com
TABLE OF CONTENTS 1. Introduction 1.1. Report Description 1.2. Market Segmentation 1.3. Research Methodology 1.4. List of Abbreviations 2. Executive Summary 3. Market Overview 3.1. Market Definition 3.2. Market Scope 3.3. Market Drivers 3.4. Market Restraints 3.5. Market Opportunities and Trends 3.6. Porter’s five force analysis 3.7. SWOT Analysis 3.8. PEST Analysis 3.9. Patent Analysis 3.10.
Impact of COVID 19 on Global Vaccines Market
4. Vaccines Market, By Technology, Market Size, Consumption and Forecast 2016 -2026 (USD Billion) 4.1. Global Vaccines Market By Technology, 2016 -2026 (USD Billion) 4.1.1.Global Vaccines Market By Conjugate vaccines 4.1.2.Global Vaccines Market By Inactivated and subunit vaccines 4.1.3.Global Vaccines Market By Live attenuated vaccines 4.1.4.Global Vaccines Market By Recombinant vaccines 4.1.5.Global Vaccines Market By Toxoid vaccines 4.2. Global Vaccines Market By Technology Share, 2016 -2026 (%) 5. Vaccines Market, By Patient Type, Market Size, Consumption and Forecast 2016 -2026 (USD Billion) 5.1. Global Vaccines Market By Patient Type, 2016 -2026 (USD Billion) 5.1.1.Global Vaccines Market By Pediatric patients 5.1.2.Global Vaccines Market By Adult patients 5.2. Global Vaccines Market By Patient Type Share, 2016 -2026 (%) 6. Vaccines Market, By Type, Market Size, Consumption and Forecast 2016 -2026 (USD Billion) Transilience Market Research | Sales@transiliencemarketresearch.com
8
6.1. Global Vaccines Market By Type, 2016 -2026 (USD Billion) 6.1.1.Global Vaccines Market By Monovalent vaccines 6.1.2.Global Vaccines Market By Multivalent vaccines 6.2. Global Vaccines Market By Type Share, 2016 -2026 (%) 7. Vaccines Market, By Disease, Market Size, Consumption and Forecast 2016 -2026 (USD Billion) 7.1. Global Vaccines Market By Disease, 2016 -2026 (USD Billion) 7.1.1.Global Vaccines Market By Cancer 7.1.2.Global Vaccines Market By Dengue 7.1.3.Global Vaccines Market By DTP 7.1.4.Global Vaccines Market By Hepatitis 7.1.5.Global Vaccines Market By Human Papilloma Virus 7.1.6.Global Vaccines Market By Influenza 7.1.7.Global Vaccines Market By Meningococcal Disease 7.1.8.Global Vaccines Market By Pneumococcal disease 7.1.9.Global Vaccines Market By Polio 7.1.10. Global Vaccines Market By Rotavirus 7.2. Global Vaccines Market By Disease Share, 2016 -2026 (%) 8. Vaccines Market, By Region Market Size, Consumption and Forecast 2016 -2026 8.1. NORTH AMERICA 8.1.1.Key Findings 8.1.2.Impact of COVID 19 8.1.3.Key market trends, growth factors and opportunities 8.1.4.North America Vaccines Market by Country 2016 -2026 (USD Billion) 8.1.5.North America Vaccines Market By Technology 2016 -2026 (USD Billion) 8.1.6.North America Vaccines Market By Type 2016 -2026 (USD Billion) 8.1.7.North America Vaccines Market By Patient Type 2016 -2026 (USD Billion) 8.1.8.North America Vaccines Market By Disease 2016 -2026 (USD Billion) 8.2. EUROPE 8.2.1.Key Findings 8.2.2.Impact of COVID 19 8.2.3.Key market trends, growth factors and opportunities 8.2.4.Europe Vaccines Market by Country 2016 -2026 (USD Billion) 8.2.5.Europe Vaccines Market By Technology 2016 -2026 (USD Billion) 8.2.6.Europe Vaccines Market By Type 2016 -2026 (USD Billion)
Transilience Market Research | Sales@transiliencemarketresearch.com
9
8.2.7.Europe Vaccines Market By Patient Type 2016 -2026 (USD Billion) 8.2.8.Europe Vaccines Market By Disease 2016 -2026 (USD Billion) 8.3. ASIA PACIFIC 8.3.1.Key Findings 8.3.2.Impact of COVID 19 8.3.3.Key market trends, growth factors and opportunities 8.3.4.Asia Pacific Vaccines Market by Country 2016 -2026 (USD Billion) 8.3.5.Asia Pacific Vaccines Market By Technology 2016 -2026 (USD Billion) 8.3.6.Asia Pacific Vaccines Market By Type 2016 -2026 (USD Billion) 8.3.7.Asia Pacific Vaccines Market By Patient Type 2016 -2026 (USD Billion) 8.3.8.Asia Pacific Vaccines Market By Disease 2016 -2026 (USD Billion) 8.4. LATIN AMERICA 8.4.1.Key Findings 8.4.2.Impact of COVID 19 8.4.3.Key market trends, growth factors and opportunities 8.4.4.Latin America Vaccines Market by Country 2016 -2026 (USD Billion) 8.4.5.Latin America Vaccines Market By Technology 2016 -2026 (USD Billion) 8.4.6.Latin America Vaccines Market By Type 2016 -2026 (USD Billion) 8.4.7.Latin America Vaccines Market By Patient Type 2016 -2026 (USD Billion) 8.4.8.Latin America Vaccines Market By Disease 2016 -2026 (USD Billion) 8.5. MIDDLE EAST AND AFRICA 8.5.1.Key Findings 8.5.2.Impact of COVID 19 8.5.3.Key market trends, growth factors and opportunities 8.5.4.Middle East and Africa Vaccines Market by Country 2016 -2026 (USD Billion) 8.5.5.Middle East and Africa Vaccines Market By Technology 2016 -2026 (USD Billion) 8.5.6.Middle East and Africa Vaccines Market By Type 2016 -2026 (USD Billion) 8.5.7.Middle East and Africa Vaccines Market By Patient Type 2016 -2026 (USD Billion) 8.5.8.Middle East and Africa Vaccines Market By Disease 2016 -2026 (USD Billion) 9. Competitive Landscape Analysis 9.1. Global Vaccines Market Company Revenue, (USD Billion), 2016-2019 9.2. Global Vaccines Market Company Share, (%), 2016-2019 10. Global Vaccines Market Price Analysis 10.1.
Global Vaccines Market Price By Regions
11. Global Vaccines Market Value Chain Analysis Transilience Market Research | Sales@transiliencemarketresearch.com
10
12. Company Profiles 12.1. 12.2. 12.3. 12.4. 12.5. 12.6. 12.7. 12.8. 12.9. 12.10. 12.11. 12.12. 12.13. 12.14.
Abbott Laboratories, Inc. AstraZeneca Plc CSL Ltd. Emergent BioSolutions, Inc. GlaxoSmithKline Plc. Janssen Pharmaceuticals, Inc. Johnson and Johnson Merck &Co., Inc. Novartis AG Pfizer, Inc. Sanofi Pasteur, Inc. Takeda Pharmaceuticals Company Ltd. Valeant Pharmaceuticals International, Inc. Others
13. Appendix 14. List of Tables 15. List of Figures
11
Transilience Market Research | Sales@transiliencemarketresearch.com
Declaimer
In response to request/orders received, Transilience Analytics provides strategic business/market analysis services to a select group of customers that are limited to publications containing valuable market information. The publication is solely for our customers’ internal use. It is acknowledged by our customer, by placing the order that no part of this strategic market analysis service is for general publication or disclosure to third party. Transilience Analytics doesn’t make any warranty for the accuracy of the data as these are primarily based on interviews and therefore, liable for fluctuation. Also, Transilience Analytics doesn’t take responsibility for incorrect information supplied by manufacturers or users. Any resale, lending, disclosure or reproduction of this publication can only be made with prior written permission from Transilience Analytics. Transmission and/or reproduction of this document by any means or in any form (includes photocopying, mechanical, electronic, recording or otherwise) are prohibited without the permission of Transilience Analytics.
12
Transilience Market Research | Sales@transiliencemarketresearch.com
About Transilience Market Research
Transilience Market Research is a one stop industry provider of actionable and timely intelligence. We publish exclusive market research reports for more than 10 industry verticals. Since our inception our mission is to deliver cost effective reliable resources to back clients in decision-making processes and business development strategies. Providing B2B research to Fortune 500 companies and consulting research services. We are committed to deliver sustainable, profitable growth through in depth market research solutions.
Contact: +91-9404545879|Email us at sales@transiliencemarketresearch.com
Follow us on:
13
Transilience Market Research | Sales@transiliencemarketresearch.com